Johnson Chemical Pharmaceutical Works Co., Ltd. (TPEX: 4747)

Market Cap	3.11B
Revenue (ttm)	616.34M
Net Income (ttm)	77.82M
Shares Out	44.93M
EPS (ttm)	1.81
PE Ratio	38.33
Forward PE	n/a
Dividend	1.50 (2.18%)
Ex-Dividend Date	Jun 21, 2024

Volume	1,000
Open	69.80
Previous Close	69.30
Day's Range	69.80 - 69.80
52-Week Range	61.20 - 103.00
Beta	-0.36
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 11, 2024

About Johnson Chemical Pharmaceutical Works

Johnson Chemical Pharmaceutical Works Co., Ltd. manufactures, imports, and sells pharmaceutical ingredients, materials, and products in Taiwan. The company offers its products in various therapeutic areas, including central nervous system, respiratory, cardiovascular, gastrointestinal, endocrine system, vitamin, anti-inflammatory, cough and cold, pain reliever, etc. It provides its products in the solid dosage form, capsule, tablet, and powder and granule, as well as nasal spray forms. Johnson Chemical Pharmaceutical Works Co., Ltd. was incorpo...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1959
• Employees: 167
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4747

Financial Performance

In 2023, Johnson Chemical Pharmaceutical Works's revenue was 606.71 million, an increase of 22.65% compared to the previous year's 494.67 million. Earnings were 79.70 million, an increase of 22.90%.